Norway Savings Bank Has $666,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Norway Savings Bank boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,218 shares of the company’s stock after purchasing an additional 397 shares during the period. Norway Savings Bank’s holdings in HCA Healthcare were worth $666,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Diversified Trust Co lifted its position in HCA Healthcare by 15.0% in the 4th quarter. Diversified Trust Co now owns 49,356 shares of the company’s stock valued at $14,814,000 after acquiring an additional 6,421 shares in the last quarter. Oliver Luxxe Assets LLC lifted its position in shares of HCA Healthcare by 2.9% in the fourth quarter. Oliver Luxxe Assets LLC now owns 12,284 shares of the company’s stock worth $3,687,000 after purchasing an additional 344 shares in the last quarter. Fortem Financial Group LLC grew its holdings in shares of HCA Healthcare by 2.8% in the 4th quarter. Fortem Financial Group LLC now owns 4,263 shares of the company’s stock valued at $1,280,000 after acquiring an additional 115 shares in the last quarter. Nordea Investment Management AB grew its stake in HCA Healthcare by 29.7% in the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after purchasing an additional 193,075 shares in the last quarter. Finally, Centre Asset Management LLC grew its stake in shares of HCA Healthcare by 6.4% in the fourth quarter. Centre Asset Management LLC now owns 4,555 shares of the company’s stock valued at $1,367,000 after buying an additional 274 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. KeyCorp reduced their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday. Morgan Stanley lowered their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their target price for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, TD Cowen decreased their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Price Performance

HCA traded up $10.31 on Tuesday, reaching $307.23. The company had a trading volume of 1,057,512 shares, compared to its average volume of 1,169,069. The company has a market cap of $77.82 billion, a price-to-earnings ratio of 13.80, a P/E/G ratio of 1.21 and a beta of 1.64. The business has a 50 day simple moving average of $325.72 and a 200 day simple moving average of $354.69. HCA Healthcare, Inc. has a 52-week low of $276.50 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.